Boston Partners cut its holdings in Regis Co. (NYSE:RGS) by 46.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 127,930 shares of the company’s stock after selling 112,770 shares during the quarter. Boston Partners’ holdings in Regis were worth $1,965,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Northpointe Capital LLC acquired a new position in shares of Regis in the 4th quarter valued at approximately $1,596,000. Acadian Asset Management LLC grew its position in shares of Regis by 5.6% in the 4th quarter. Acadian Asset Management LLC now owns 139,301 shares of the company’s stock valued at $2,141,000 after purchasing an additional 7,389 shares during the period. California Public Employees Retirement System grew its position in shares of Regis by 5.9% in the 3rd quarter. California Public Employees Retirement System now owns 217,872 shares of the company’s stock valued at $3,109,000 after purchasing an additional 12,089 shares during the period. Oaktree Capital Management LP acquired a new position in shares of Regis in the 3rd quarter valued at approximately $4,593,000. Finally, OxFORD Asset Management LLP acquired a new position in shares of Regis in the 3rd quarter valued at approximately $1,146,000. Institutional investors and hedge funds own 95.27% of the company’s stock.
Several equities analysts recently issued reports on RGS shares. Jefferies Group boosted their price objective on Regis from $17.00 to $18.00 and gave the company a “buy” rating in a research report on Wednesday, November 1st. Zacks Investment Research cut Regis from a “hold” rating to a “sell” rating in a research note on Tuesday, December 12th. Finally, KeyCorp started coverage on Regis in a research note on Wednesday, December 20th. They issued a “sector weight” rating on the stock. Two research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $17.50.
Regis (NYSE:RGS) last released its earnings results on Thursday, February 1st. The company reported $0.06 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.02 by $0.04. The firm had revenue of $308.52 million for the quarter, compared to analysts’ expectations of $316.30 million. Regis had a positive return on equity of 1.68% and a negative net margin of 0.51%. equities research analysts expect that Regis Co. will post 0.37 earnings per share for the current fiscal year.
In other news, Director David Patrick Williams bought 5,000 shares of the business’s stock in a transaction on Thursday, February 8th. The shares were purchased at an average price of $15.50 per share, for a total transaction of $77,500.00. Following the purchase, the director now owns 96,861 shares of the company’s stock, valued at approximately $1,501,345.50. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 24.00% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another domain, it was stolen and republished in violation of U.S. & international copyright and trademark laws. The original version of this article can be accessed at https://www.chaffeybreeze.com/2018/02/15/regis-co-rgs-shares-sold-by-boston-partners.html.
Regis Company Profile
Regis Corporation owns, franchises and operates beauty salons. The Company operates through two segments: North American Value and North American Premium. As of June 30, 2016, the Company’s North American Value salon operations consisted of 5,784 Company-owned salons and 2,496 franchised salons operating in the United States, Canada and Puerto Rico.
Want to see what other hedge funds are holding RGS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Regis Co. (NYSE:RGS).
Receive News & Ratings for Regis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regis and related companies with MarketBeat.com's FREE daily email newsletter.